ChromaDex Management
Management criteria checks 3/4
ChromaDex's CEO is Rob Fried, appointed in Jun 2018, has a tenure of 5.83 years. total yearly compensation is $1.16M, comprised of 43.1% salary and 56.9% bonuses, including company stock and options. directly owns 2.09% of the company’s shares, worth $5.83M. The average tenure of the management team and the board of directors is 4.2 years and 7 years respectively.
Key information
Rob Fried
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 43.1% |
| CEO tenure | 5.8yrs |
| CEO ownership | 2.1% |
| Management average tenure | 4.2yrs |
| Board average tenure | 7yrs |
Recent management updates
Recent updates
Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?
Apr 05
Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet
Feb 28ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price
Jan 29Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues
Jun 08We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely
Mar 31ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé
Oct 11ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale
Oct 03ChromaDex in pact to introduce anti-aging compound in Brazil
Sep 01Ayana Bio appoints Frank Jaksch as CEO
Aug 24ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent
Aug 15Some ChromaDex Corporation (NASDAQ:CDXC) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 15We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate
Mar 03Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth
Nov 19When Should You Buy ChromaDex Corporation (NASDAQ:CDXC)?
Sep 14We Discuss Whether ChromaDex Corporation's (NASDAQ:CDXC) CEO Is Due For A Pay Rise
Jun 11ChromaDex to sell Tru Niagen in 3,800 Walmart stores in the U.S.
Jun 07Is There Now An Opportunity In ChromaDex Corporation (NASDAQ:CDXC)?
Jun 02We Think ChromaDex (NASDAQ:CDXC) Can Easily Afford To Drive Business Growth
May 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$5m |
| Sep 30 2023 | n/a | n/a | -US$6m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$11m |
| Dec 31 2022 | US$1m | US$500k | -US$17m |
| Sep 30 2022 | n/a | n/a | -US$20m |
| Jun 30 2022 | n/a | n/a | -US$28m |
| Mar 31 2022 | n/a | n/a | -US$27m |
| Dec 31 2021 | US$1m | US$500k | -US$27m |
| Sep 30 2021 | n/a | n/a | -US$28m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | n/a | n/a | -US$21m |
| Dec 31 2020 | US$1m | US$519k | -US$20m |
| Sep 30 2020 | n/a | n/a | -US$23m |
| Jun 30 2020 | n/a | n/a | -US$26m |
| Mar 31 2020 | n/a | n/a | -US$30m |
| Dec 31 2019 | US$2m | US$487k | -US$32m |
| Sep 30 2019 | n/a | n/a | -US$32m |
| Jun 30 2019 | n/a | n/a | -US$33m |
| Mar 31 2019 | n/a | n/a | -US$33m |
| Dec 31 2018 | US$5m | US$379k | -US$33m |
| Sep 30 2018 | n/a | n/a | -US$34m |
| Jun 30 2018 | n/a | n/a | -US$29m |
| Mar 31 2018 | n/a | n/a | -US$23m |
| Dec 30 2017 | US$4m | US$231k | -US$17m |
Compensation vs Market: Rob's total compensation ($USD1.16M) is about average for companies of similar size in the US market ($USD1.60M).
Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.
CEO
Rob Fried (63 yo)
5.8yrs
Tenure
US$1,158,850
Compensation
Mr. Robert N. Fried, also known as Rob, has been the Chief Executive Officer of ChromaDex Corp. since June 22, 2018 and its a Director since July 2015. Mr. Fried was the Chief Operating Officer of ChromaDe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 24.2yrs | US$482.35k | 3.06% $ 8.5m | |
| CEO & Director | 5.8yrs | US$1.16m | 2.09% $ 5.8m | |
| Chief Financial Officer | 1.7yrs | US$842.39k | 0.038% $ 105.8k | |
| Senior Vice President of Global Regulatory & Scientific Affairs | 4.2yrs | no data | no data | |
| Senior VP of Legal & Corporate Secretary | 2.3yrs | no data | no data | |
| Vice President of Global Marketing & Communications | no data | no data | no data | |
| Senior Vice President of People Matters | no data | no data | no data | |
| Managing Director of Asia Pacific | 5.5yrs | no data | no data | |
| Senior Vice President of Business Development | less than a year | no data | no data | |
| Head of Media Relations & Partnerships | no data | no data | no data |
4.2yrs
Average Tenure
55yo
Average Age
Experienced Management: CDXC's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 24.2yrs | US$482.35k | 3.06% $ 8.5m | |
| CEO & Director | 8.8yrs | US$1.16m | 2.09% $ 5.8m | |
| Member of Scientific Advisory Board | 6.8yrs | no data | no data | |
| Lead Independent Director | 7.1yrs | US$97.63k | 0.0093% $ 25.8k | |
| Chairman of the Scientific Advisory Board | 9.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.6yrs | no data | no data | |
| Independent Director | 2yrs | US$124.67k | 0% $ 0 | |
| Non-Executive Director | 6.7yrs | US$66.58k | 0% $ 0 | |
| Independent Director | 2yrs | US$119.78k | 0% $ 0 | |
| Chief Scientific Advisor & Member of Scientific Advisory Board | 9.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.9yrs | no data | no data | |
| Member of the Scientific Advisory Board | 4.8yrs | no data | no data |
7.0yrs
Average Tenure
62.5yo
Average Age
Experienced Board: CDXC's board of directors are considered experienced (7 years average tenure).